pI: 8.6597 |
Length (AA): 424 |
MW (Da): 48675 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 10
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
122 | 373 | 1xme (A) | 16 | 285 | 10.00 | 0.000047 | 0.02 | 0.74 | -1.36 |
61 | 288 | 1s5l (D) | 35 | 281 | 11.00 | 0.00053 | 0.01 | 0.350936 | 1.82 |
92 | 291 | 4hyj (A) | 9 | 234 | 9.00 | 0.29 | 0.02 | 0.450898 | -0.23 |
147 | 254 | 3lnm (D) | 160 | 303 | 33.00 | 0.29 | 0.03 | 0.188917 | 1.98 |
58 | 292 | 4j72 (A) | 17 | 280 | 12.00 | 0.26 | 0.01 | 0.637845 | -0.2 |
59 | 317 | 2z73 (A) | 39 | 321 | 10.00 | 0.55 | 0.01 | 0.521449 | 0.73 |
147 | 254 | 3lnm (D) | 160 | 303 | 32.00 | 0.75 | 0.02 | 0.189817 | 1.86 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, merozoite, sporozoite, early ring, early trophozoite, late ring, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | early schizont, late schizont, late trophozoite. | PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | gametocyte, Sporozoite, Male Gametocyte. | PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Oocyst, Female Gametocyte. | Zanghi G Lasonder E |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_133154)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G24460 | CRT (chloroquine-resistance transporter)-like transporter 2 |
Arabidopsis thaliana | AT5G12170 | CRT (chloroquine-resistance transporter)-like transporter 3 |
Arabidopsis thaliana | AT5G19380 | CRT (chloroquine-resistance transporter)-like transporter 1 |
Babesia bovis | BBOV_III003790 | conserved hypothetical protein |
Cryptosporidium hominis | Chro.60564 | transporter |
Cryptosporidium parvum | cgd6_4890 | transporter protein with conserved Zn ribbon C11C7CxxC |
Dictyostelium discoideum | DDB_G0277321 | chloroquine resistance transporter-like protein |
Dictyostelium discoideum | DDB_G0270204 | chloroquine resistance transporter-like protein |
Dictyostelium discoideum | DDB_G0276943 | chloroquine resistance transporter-like protein |
Neospora caninum | NCLIV_057130 | hypothetical protein, conserved |
Oryza sativa | 4325409 | Os01g0955700 |
Oryza sativa | 4352325 | Os12g0511300 |
Plasmodium berghei | PBANKA_1219500 | chloroquine resistance transporter, putative |
Plasmodium falciparum | PF3D7_0709000 | chloroquine resistance transporter |
Plasmodium knowlesi | PKNH_0107600 | chloroquine resistance transporter, putative |
Plasmodium vivax | PVX_087980 | chloroquine resistance transporter, putative |
Plasmodium yoelii | PY05061 | putative transporter protein CG10 |
Toxoplasma gondii | TGME49_313930 | transmembrane protein |
Theileria parva | TP02_0224 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_1219500 | Plasmodium berghei | Essential | plasmo |
TGME49_313930 | Toxoplasma gondii | Probably non-essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | multi-cellular organism (CARO:0000012) | bloodstream stage (PLO:0040) | in vivo inhibition (TDR:00016) | Plasmodium falciparum | 1402 6701 503934 567171 |
Annotator: | saralph@unimelb.edu.au. | Comment: | 012/Mar/09. | References: | 15240840 15944738 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Compound | Source | Reference |
---|---|---|
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
ChEMBL23 | References | |
ChEMBL23 | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
ChEMBL23 | References |
2 literature references were collected for this gene.